chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Blood test, Computerised tomogram, Guillain-Barre syndrome, Immunoglobulin therapy
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lumbar puncture abnormal, Magnetic resonance imaging, Nerve conduction studies abnormal
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Bell's palsy, Dysstasia, Electromyogram abnormal, Facial paralysis
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Gait inability, Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal abnormal
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nerve conduction studies abnormal, Scan with contrast abnormal
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Guillain-Barre syndrome
Clinical narrative: GUILLAIN-BARRE SYNDROME; This spontaneous report was received from a patient and concerned a male of unspecified age, race and ethnicity. The patient's weight, height and medical history were not reported. The patient received COVID-19 vaccine Ad26.CoV2.S (suspension for injection, intramuscular, batch number and expiry date unknown) dose, vaccination date and site of injection not reported for prophylactic vaccination. The company is unable to perform follow-up to request the batch number of the vaccine. No concomitant medications were reported. On an unspecified date, a few weeks after vaccination, the patient was reported to have experienced unusual symptoms. He reported that he had "loss of sensation in my legs. It felt like my legs were going to give out and that only happened like once or twice" (entered as loss of sensation in legs). Over time, his mobility worsened and he reported that for a short period of time, he experienced pain in his legs and needed to use a walker. The next day, he reported not being able to walk at all. The patient was subsequently diagnosed with Guillain-Barre Syndrome. The article stated the inflammatory response led to this condition. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the Guillain-Barre Syndrome was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:  A male patient of unspecified age and ethnicity who was diagnosed with Guillain-Barre Syndrome (GBS) a "few weeks" after receiving Janssen Covid-19 vaccine. Symptoms reported were "loss of sensation in my legs, as if they were going to give out", pain in his legs that worsened from needing a walker to ambulate to not being able to walk; "Inflammatory response" led to  his condition.  No other details reported.  Information is limited in this case, and the occurrence of the events  could represent background incidence of such events in the general population. However, a relationship with Janssen Covid-19 vaccine cannot be ruled out and thus the relationship is considered indeterminate.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient was hospitalized and died within 60 days of receiving a COVID vaccine series
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was hospitalized and died within 60 days of receiving a COVID vaccine series
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Feeling abnormal, Flushing, Paraesthesia oral
Clinical narrative: Pt had second dose today of Covid vaccine.  About five minutes after receiving it, noted tongue itching, nausea, and chest tightness.  Had a sensation of swelling in her tongue and lips, but not sure if they actually swelled or not.  No dizziness or syncope.  No shortness of breath.  No vomiting, abdominal pain.  No rash, diffuse pruritus, urticaria.  No prior allergic response to vaccines, but has had multiple prior drug allergies, including anaphylaxis.  Was given IM epinephrine immediately, and also took benadryl PTA.  Upon arrival, feeling better.  Only residual symptom is tongue itching.   ED Visit, Non-prescription medication, Prescription medication
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Lip swelling, Nausea, Swollen tongue, Tongue pruritus
Clinical narrative: Pt had second dose today of Covid vaccine.  About five minutes after receiving it, noted tongue itching, nausea, and chest tightness.  Had a sensation of swelling in her tongue and lips, but not sure if they actually swelled or not.  No dizziness or syncope.  No shortness of breath.  No vomiting, abdominal pain.  No rash, diffuse pruritus, urticaria.  No prior allergic response to vaccines, but has had multiple prior drug allergies, including anaphylaxis.  Was given IM epinephrine immediately, and also took benadryl PTA.  Upon arrival, feeling better.  Only residual symptom is tongue itching.   ED Visit, Non-prescription medication, Prescription medication
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arteriovenous malformation, Computerised tomogram, Craniotomy, Haemorrhage intracranial, Headache
Clinical narrative: Constant headaches mainly frontal headache that is sharp and horizontal between the ears at times; Muscle aches; Tail bone pain; Back pain; Significant fatigue; lymphadenopathy in neck; This is a spontaneous report from a contactable other health care professional. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), intramuscularly in the right arm on 11Mar2021 at 20:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Mar2021 at 15:00, the patient experienced constant headaches for the last 11 days. Mainly frontal headache that was sharp and horizontal between the ears at the time. The patient experienced muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue on 13Mar2021 at 15:00. Therapeutic measures were taken as a result of events constant headache, muscle ache, tail bone pain, back pain and lymphadenopathy in neck and included treatment with TYLENOL and ibuprofen. The adverse events resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care.  The clinical outcome of the events headaches, muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Intensive care, Intraventricular haemorrhage, Magnetic resonance imaging head abnormal
Clinical narrative: Constant headaches mainly frontal headache that is sharp and horizontal between the ears at times; Muscle aches; Tail bone pain; Back pain; Significant fatigue; lymphadenopathy in neck; This is a spontaneous report from a contactable other health care professional. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), intramuscularly in the right arm on 11Mar2021 at 20:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Mar2021 at 15:00, the patient experienced constant headaches for the last 11 days. Mainly frontal headache that was sharp and horizontal between the ears at the time. The patient experienced muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue on 13Mar2021 at 15:00. Therapeutic measures were taken as a result of events constant headache, muscle ache, tail bone pain, back pain and lymphadenopathy in neck and included treatment with TYLENOL and ibuprofen. The adverse events resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care.  The clinical outcome of the events headaches, muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Coccydynia, Fatigue, Headache, Lymphadenopathy
Clinical narrative: Constant headaches mainly frontal headache that is sharp and horizontal between the ears at times; Muscle aches; Tail bone pain; Back pain; Significant fatigue; lymphadenopathy in neck; This is a spontaneous report from a contactable other health care professional. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), intramuscularly in the right arm on 11Mar2021 at 20:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Mar2021 at 15:00, the patient experienced constant headaches for the last 11 days. Mainly frontal headache that was sharp and horizontal between the ears at the time. The patient experienced muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue on 13Mar2021 at 15:00. Therapeutic measures were taken as a result of events constant headache, muscle ache, tail bone pain, back pain and lymphadenopathy in neck and included treatment with TYLENOL and ibuprofen. The adverse events resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care.  The clinical outcome of the events headaches, muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myalgia
Clinical narrative: Constant headaches mainly frontal headache that is sharp and horizontal between the ears at times; Muscle aches; Tail bone pain; Back pain; Significant fatigue; lymphadenopathy in neck; This is a spontaneous report from a contactable other health care professional. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), intramuscularly in the right arm on 11Mar2021 at 20:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Mar2021 at 15:00, the patient experienced constant headaches for the last 11 days. Mainly frontal headache that was sharp and horizontal between the ears at the time. The patient experienced muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue on 13Mar2021 at 15:00. Therapeutic measures were taken as a result of events constant headache, muscle ache, tail bone pain, back pain and lymphadenopathy in neck and included treatment with TYLENOL and ibuprofen. The adverse events resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care.  The clinical outcome of the events headaches, muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: This is a spontaneous report from a contactable consumer (patient himself). A 55-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202), via an unspecified route of administration, administered in arm Left on 04Mar2021 (at the age of 55-year-old) as dose 1, single for covid-19 immunisation. Medical history included hypertensive. There were no concomitant medications. The patient reported that after first dose of vaccination he felt some symptoms that lasted about 3-4 days. The onset of low grade fever, body aches, fatigue, soreness, headache, chills symptoms were on the 12Mar2021. The symptoms were mild on the 14Mar2021. On 14Mar2021 the patient's fever broke, it was low grade it barely reached 100.4, he had body aches that went away and he was feeling good since then. The patient also had fatigue, body aches, soreness, a headache, and chills. The patient still had a bit of a build up of a raspy throat in the morning. The patient had these allergic reaction type symptoms before so he thought it was allergies, he did not think that the covid test would come back positive. All of these symptoms were between 12Mar2021 and 14Mar2021. The patient wants to know if it was safe for the second dose on 25Mar2021. The patient underwent lab tests which included fever: low grade it barely reached 100.4 on 14Mar2021, COVID-19 virus test: positive on 12Mar2021, positive on 15Mar2021, negative on 23Mar2021. The outcome of the event was resolved on 23Mar2021. No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, COVID-19, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient himself). A 55-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6202), via an unspecified route of administration, administered in arm Left on 04Mar2021 (at the age of 55-year-old) as dose 1, single for covid-19 immunisation. Medical history included hypertensive. There were no concomitant medications. The patient reported that after first dose of vaccination he felt some symptoms that lasted about 3-4 days. The onset of low grade fever, body aches, fatigue, soreness, headache, chills symptoms were on the 12Mar2021. The symptoms were mild on the 14Mar2021. On 14Mar2021 the patient's fever broke, it was low grade it barely reached 100.4, he had body aches that went away and he was feeling good since then. The patient also had fatigue, body aches, soreness, a headache, and chills. The patient still had a bit of a build up of a raspy throat in the morning. The patient had these allergic reaction type symptoms before so he thought it was allergies, he did not think that the covid test would come back positive. All of these symptoms were between 12Mar2021 and 14Mar2021. The patient wants to know if it was safe for the second dose on 25Mar2021. The patient underwent lab tests which included fever: low grade it barely reached 100.4 on 14Mar2021, COVID-19 virus test: positive on 12Mar2021, positive on 15Mar2021, negative on 23Mar2021. The outcome of the event was resolved on 23Mar2021. No follow-up attempts are possible. No further information is expected.
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Age: 79.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series, patient passed away on 5/30
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series, patient passed away on 5/30
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Lab specimen collected on 4/28/2021. On 4/30/2021 at 11:50 case manager performed case investigation interview and charted, "Client stated that symptoms (head ache, cough) began 4/25 and continue today."
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Headache, Laboratory test
Clinical narrative: Lab specimen collected on 4/28/2021. On 4/30/2021 at 11:50 case manager performed case investigation interview and charted, "Client stated that symptoms (head ache, cough) began 4/25 and continue today."
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Specimen collection date was 4/28/2021. Two days later on April 30th at 13:07 when case investigation interview was conducted, case manager wrote, "Client stated that he was asymptomatic when tested.  He later developed body aches, chills, and head aches, which continues today.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Laboratory test, Pain
Clinical narrative: Specimen collection date was 4/28/2021. Two days later on April 30th at 13:07 when case investigation interview was conducted, case manager wrote, "Client stated that he was asymptomatic when tested.  He later developed body aches, chills, and head aches, which continues today.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Specimen collection date of 5/2/2021 at a store/pharmacy. On 5/10/2021 case manager performed case investigation interview and charted, "Client stated that symptoms (runny nose, cough, head ache, body aches) began on 4/29.  Current symptoms are head ache, cough, and body aches.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cough, Headache, Laboratory test, Pain, Rhinorrhoea
Clinical narrative: Specimen collection date of 5/2/2021 at a store/pharmacy. On 5/10/2021 case manager performed case investigation interview and charted, "Client stated that symptoms (runny nose, cough, head ache, body aches) began on 4/29.  Current symptoms are head ache, cough, and body aches.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Vertigo
Clinical narrative: Vertigo; This is a spontaneous report from a contactable consumer. A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 02Feb2021 (at the age of 69 years old) as unknown dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. She got the vaccine last Monday, 02Feb2021, later in the day around 9:30 pm, she started to get vertigo. She does not know if it is one of the side effects and would like to know. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This is a spontaneous report from a contactable consumer. A 69-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 02Feb2021 (at the age of 69 years old) as unknown dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. She got the vaccine last Monday, 02Feb2021, later in the day around 9:30 pm, she started to get vertigo. She does not know if it is one of the side effects and would like to know. The outcome of the event was unknown.  Information about lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Specimen collected on 5/3/2021 at Hospital-70000. On 5/4/2021 at 14:24 case manager performed case investigation interview and charted, "Client states he was asymptomatic when tested and was tested as a pre-procedure screening at facility.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test, Unevaluable event
Clinical narrative: Specimen collected on 5/3/2021 at Hospital-70000. On 5/4/2021 at 14:24 case manager performed case investigation interview and charted, "Client states he was asymptomatic when tested and was tested as a pre-procedure screening at facility.
Age: 87.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was hospitalized multiple times and died within 60 days of receiving a COVID vaccine
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as dose 2, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On an unspecified date, 2 weeks after receiving second dose, the patient experienced shingles and hospitalized for an afternoon. Doctors said that the vaccine could have woke up the sleeping virus in the patient's body. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as dose 2, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date, as single dose for COVID-19 immunization. On an unspecified date, 2 weeks after receiving second dose, the patient experienced shingles and hospitalized for an afternoon. Doctors said that the vaccine could have woke up the sleeping virus in the patient's body. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; extremely painful; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot number: unknown), dose 2 via an unspecified route of administration on an unspecified date as 2nd single dose for COVID-19 immunization. No medical and concomitant medication history were reported. The patient experienced 2 weeks after receiving 2nd dose of vaccine patient developed shingles. It was reported that, patient knew 6 other people of patients age group (50s-60s) that also developed shingles as well, 14 days after vaccine. Patient had to be hospitalized for an afternoon and the doctors said that the vaccine could have definitely woke up the sleeping virus in patients body. This had been an extremely painful experience, but still had gotten the COVID-19 vaccine. Doctors told let Pfizer know about reaction. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Herpes zoster, Pain
Clinical narrative: shingles; extremely painful; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot number: unknown), dose 2 via an unspecified route of administration on an unspecified date as 2nd single dose for COVID-19 immunization. No medical and concomitant medication history were reported. The patient experienced 2 weeks after receiving 2nd dose of vaccine patient developed shingles. It was reported that, patient knew 6 other people of patients age group (50s-60s) that also developed shingles as well, 14 days after vaccine. Patient had to be hospitalized for an afternoon and the doctors said that the vaccine could have definitely woke up the sleeping virus in patients body. This had been an extremely painful experience, but still had gotten the COVID-19 vaccine. Doctors told let Pfizer know about reaction. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: When I got my vaccine, the nurse accidently gave me 2 shots in the same left arm. Within 5 minutes, I got a bad headache, but it went away quickly. The nurse and the pharmacist came over to assess me and asked me to wait for 30 minutes.   While in the waiting area, my muscle started to ache, but overall, I felt ok. I decided to go home. At home, I started to feel nauseated and feeling extremely tired. The next day, both my arms started to feel sore and painful, and I started to have chest pains. I spoke to my doctors to let them know what happened, my symptoms and they will follow me. My cardiac symptoms include, feeling heavy pressure, chest pain and chest tightness. I went to see my cardiologist and did a stress test and he wanted to do a catherization for a condition prior to the vaccine. I was prescribed Metoprolol. I also had blood work and ECHO. The stress test showed poor blood flow. On 6/22/2021, I did have a catherization. On 6/26/2021 I went to the ER to remove my pressure pack bandage that was placed during the catherization. In the ER, my blood pressure was high, I was wheezing, having chest pains and my leg was hurting. The ER did a cardiac follow up, removed my pressure pack bandage and replaced a new pressure pack bandage. I am to follow up with my cardiologist.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac dysfunction, Catheterisation cardiac, Chest discomfort, Chest pain
Clinical narrative: When I got my vaccine, the nurse accidently gave me 2 shots in the same left arm. Within 5 minutes, I got a bad headache, but it went away quickly. The nurse and the pharmacist came over to assess me and asked me to wait for 30 minutes.   While in the waiting area, my muscle started to ache, but overall, I felt ok. I decided to go home. At home, I started to feel nauseated and feeling extremely tired. The next day, both my arms started to feel sore and painful, and I started to have chest pains. I spoke to my doctors to let them know what happened, my symptoms and they will follow me. My cardiac symptoms include, feeling heavy pressure, chest pain and chest tightness. I went to see my cardiologist and did a stress test and he wanted to do a catherization for a condition prior to the vaccine. I was prescribed Metoprolol. I also had blood work and ECHO. The stress test showed poor blood flow. On 6/22/2021, I did have a catherization. On 6/26/2021 I went to the ER to remove my pressure pack bandage that was placed during the catherization. In the ER, my blood pressure was high, I was wheezing, having chest pains and my leg was hurting. The ER did a cardiac follow up, removed my pressure pack bandage and replaced a new pressure pack bandage. I am to follow up with my cardiologist.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Fatigue, Headache, Hypertension, Myalgia
Clinical narrative: When I got my vaccine, the nurse accidently gave me 2 shots in the same left arm. Within 5 minutes, I got a bad headache, but it went away quickly. The nurse and the pharmacist came over to assess me and asked me to wait for 30 minutes.   While in the waiting area, my muscle started to ache, but overall, I felt ok. I decided to go home. At home, I started to feel nauseated and feeling extremely tired. The next day, both my arms started to feel sore and painful, and I started to have chest pains. I spoke to my doctors to let them know what happened, my symptoms and they will follow me. My cardiac symptoms include, feeling heavy pressure, chest pain and chest tightness. I went to see my cardiologist and did a stress test and he wanted to do a catherization for a condition prior to the vaccine. I was prescribed Metoprolol. I also had blood work and ECHO. The stress test showed poor blood flow. On 6/22/2021, I did have a catherization. On 6/26/2021 I went to the ER to remove my pressure pack bandage that was placed during the catherization. In the ER, my blood pressure was high, I was wheezing, having chest pains and my leg was hurting. The ER did a cardiac follow up, removed my pressure pack bandage and replaced a new pressure pack bandage. I am to follow up with my cardiologist.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pain in extremity, Wheezing
Clinical narrative: When I got my vaccine, the nurse accidently gave me 2 shots in the same left arm. Within 5 minutes, I got a bad headache, but it went away quickly. The nurse and the pharmacist came over to assess me and asked me to wait for 30 minutes.   While in the waiting area, my muscle started to ache, but overall, I felt ok. I decided to go home. At home, I started to feel nauseated and feeling extremely tired. The next day, both my arms started to feel sore and painful, and I started to have chest pains. I spoke to my doctors to let them know what happened, my symptoms and they will follow me. My cardiac symptoms include, feeling heavy pressure, chest pain and chest tightness. I went to see my cardiologist and did a stress test and he wanted to do a catherization for a condition prior to the vaccine. I was prescribed Metoprolol. I also had blood work and ECHO. The stress test showed poor blood flow. On 6/22/2021, I did have a catherization. On 6/26/2021 I went to the ER to remove my pressure pack bandage that was placed during the catherization. In the ER, my blood pressure was high, I was wheezing, having chest pains and my leg was hurting. The ER did a cardiac follow up, removed my pressure pack bandage and replaced a new pressure pack bandage. I am to follow up with my cardiologist.
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Age: 90.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Patient was hospitalized multiple times within 60 days of receiving a COVID vaccine series and later passed away
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac arrest, Chest discomfort, Death, Dyspnoea
Clinical narrative: Per ER notes: Pt. 40 y.o. female who presented to the ED by ambulance for cardiac arrest. Patient called 911 for shortness of breath. Per paramedics, she was in severe respiratory distress when they got there and her oxygen saturation was in the 70s, tachycardic, and patient was cyanotic with blue lips. She then collapsed and went into cardiac arrest around 1205. CPR started. She was initially in asystole then PEQ and then asystole. Bilateral tibial IOs placed and given epi x 4 and bicarb x1. Patient has hx of leukemia. Received covid 19 vaccine 1 week ago and wasn't feeling well all week.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Pulmonary embolism, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: Per ER notes: Pt. 40 y.o. female who presented to the ED by ambulance for cardiac arrest. Patient called 911 for shortness of breath. Per paramedics, she was in severe respiratory distress when they got there and her oxygen saturation was in the 70s, tachycardic, and patient was cyanotic with blue lips. She then collapsed and went into cardiac arrest around 1205. CPR started. She was initially in asystole then PEQ and then asystole. Bilateral tibial IOs placed and given epi x 4 and bicarb x1. Patient has hx of leukemia. Received covid 19 vaccine 1 week ago and wasn't feeling well all week.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Cyanosis, Dyspnoea, Intraosseous access placement, Malaise
Clinical narrative: Per ER notes: Pt. 40 y.o. female who presented to the ED by ambulance for cardiac arrest. Patient called 911 for shortness of breath. Per paramedics, she was in severe respiratory distress when they got there and her oxygen saturation was in the 70s, tachycardic, and patient was cyanotic with blue lips. She then collapsed and went into cardiac arrest around 1205. CPR started. She was initially in asystole then PEQ and then asystole. Bilateral tibial IOs placed and given epi x 4 and bicarb x1. Patient has hx of leukemia. Received covid 19 vaccine 1 week ago and wasn't feeling well all week.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation decreased, Pulseless electrical activity, Respiratory distress, Resuscitation, Syncope
Clinical narrative: Per ER notes: Pt. 40 y.o. female who presented to the ED by ambulance for cardiac arrest. Patient called 911 for shortness of breath. Per paramedics, she was in severe respiratory distress when they got there and her oxygen saturation was in the 70s, tachycardic, and patient was cyanotic with blue lips. She then collapsed and went into cardiac arrest around 1205. CPR started. She was initially in asystole then PEQ and then asystole. Bilateral tibial IOs placed and given epi x 4 and bicarb x1. Patient has hx of leukemia. Received covid 19 vaccine 1 week ago and wasn't feeling well all week.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tachycardia
Clinical narrative: Per ER notes: Pt. 40 y.o. female who presented to the ED by ambulance for cardiac arrest. Patient called 911 for shortness of breath. Per paramedics, she was in severe respiratory distress when they got there and her oxygen saturation was in the 70s, tachycardic, and patient was cyanotic with blue lips. She then collapsed and went into cardiac arrest around 1205. CPR started. She was initially in asystole then PEQ and then asystole. Bilateral tibial IOs placed and given epi x 4 and bicarb x1. Patient has hx of leukemia. Received covid 19 vaccine 1 week ago and wasn't feeling well all week.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test abnormal, Dizziness, Hepatic enzyme increased, Pain in extremity, Pyrexia
Clinical narrative: Patient had fever, from 5/26/21 to 6/2/21 patients fever was 105, body aches, blurred vision, dizziness, ringing in the ears. feeling tired, rash all over body.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, SARS-CoV-2 test negative, Tinnitus
Clinical narrative: Patient had fever, from 5/26/21 to 6/2/21 patients fever was 105, body aches, blurred vision, dizziness, ringing in the ears. feeling tired, rash all over body.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Pain, Pyrexia, Rash
Clinical narrative: Patient had fever, from 5/26/21 to 6/2/21 patients fever was 105, body aches, blurred vision, dizziness, ringing in the ears. feeling tired, rash all over body.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus, Vision blurred
Clinical narrative: Patient had fever, from 5/26/21 to 6/2/21 patients fever was 105, body aches, blurred vision, dizziness, ringing in the ears. feeling tired, rash all over body.